Literature DB >> 27173969

What Is New in Melanoma Genetics and Treatment?

Simone Ribero1, Caterina Longo, Dan Glass, Paul Nathan, Veronique Bataille.   

Abstract

New therapies for advanced melanoma have led to major advances, which, for the first time, showed improved survival for patients with this very challenging neoplasm. These new treatments are based on gene-targeted therapies or stimulation of immune responses. However, these treatments are not without challenges in terms of resistance and toxicity. Physicians should be aware of these side effects as prompt treatment may save lives. Melanoma genetics is also unravelling new genetic risk factors involving telomere genes as well as new gene pathways at the somatic level which may soon become therapeutic targets. It is also shedding new light onto the pathology of this tumour with links to neural diseases and longevity.
© 2016 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27173969     DOI: 10.1159/000445767

Source DB:  PubMed          Journal:  Dermatology        ISSN: 1018-8665            Impact factor:   5.366


  7 in total

Review 1.  Prognostic and Predictive Biomarkers in Stage III Melanoma: Current Insights and Clinical Implications.

Authors:  Luca Tonella; Valentina Pala; Renata Ponti; Marco Rubatto; Giuseppe Gallo; Luca Mastorino; Gianluca Avallone; Martina Merli; Andrea Agostini; Paolo Fava; Luca Bertero; Rebecca Senetta; Simona Osella-Abate; Simone Ribero; Maria Teresa Fierro; Pietro Quaglino
Journal:  Int J Mol Sci       Date:  2021-04-27       Impact factor: 5.923

Review 2.  Skin cancer screening: recommendations for data-driven screening guidelines and a review of the US Preventive Services Task Force controversy.

Authors:  Mariah M Johnson; Sancy A Leachman; Lisa G Aspinwall; Lee D Cranmer; Clara Curiel-Lewandrowski; Vernon K Sondak; Clara E Stemwedel; Susan M Swetter; John Vetto; Tawnya Bowles; Robert P Dellavalle; Larisa J Geskin; Douglas Grossman; Kenneth F Grossmann; Jason E Hawkes; Joanne M Jeter; Caroline C Kim; John M Kirkwood; Aaron R Mangold; Frank Meyskens; Michael E Ming; Kelly C Nelson; Michael Piepkorn; Brian P Pollack; June K Robinson; Arthur J Sober; Shannon Trotter; Suraj S Venna; Sanjiv Agarwala; Rhoda Alani; Bruce Averbook; Anna Bar; Mirna Becevic; Neil Box; William E Carson; Pamela B Cassidy; Suephy C Chen; Emily Y Chu; Darrel L Ellis; Laura K Ferris; David E Fisher; Kari Kendra; David H Lawson; Philip D Leming; Kim A Margolin; Svetomir Markovic; Mary C Martini; Debbie Miller; Debjani Sahni; William H Sharfman; Jennifer Stein; Alexander J Stratigos; Ahmad Tarhini; Matthew H Taylor; Oliver J Wisco; Michael K Wong
Journal:  Melanoma Manag       Date:  2017-03-01

3.  Noncalcemic 20-hydroxyvitamin D3 inhibits human melanoma growth in in vitro and in vivo models.

Authors:  Cezary Skobowiat; Allen S W Oak; Tae-Kang Kim; Chuan He Yang; Lawrence M Pfeffer; Robert C Tuckey; Andrzej T Slominski
Journal:  Oncotarget       Date:  2017-02-07

4.  WIPI1, BAG1, and PEX3 Autophagy-Related Genes Are Relevant Melanoma Markers.

Authors:  Daniela D'Arcangelo; Claudia Giampietri; Mario Muscio; Francesca Scatozza; Francesco Facchiano; Antonio Facchiano
Journal:  Oxid Med Cell Longev       Date:  2018-12-02       Impact factor: 6.543

Review 5.  Current Controversies and Challenges on BRAF V600K-Mutant Cutaneous Melanoma.

Authors:  Alessandro Nepote; Gianluca Avallone; Simone Ribero; Francesco Cavallo; Gabriele Roccuzzo; Luca Mastorino; Claudio Conforti; Luca Paruzzo; Stefano Poletto; Fabrizio Carnevale Schianca; Pietro Quaglino; Massimo Aglietta
Journal:  J Clin Med       Date:  2022-02-04       Impact factor: 4.241

Review 6.  Oxidative Stress-Related Mechanisms in Melanoma and in the Acquired Resistance to Targeted Therapies.

Authors:  Stefania Pizzimenti; Simone Ribero; Marie Angele Cucci; Margherita Grattarola; Chiara Monge; Chiara Dianzani; Giuseppina Barrera; Giuliana Muzio
Journal:  Antioxidants (Basel)       Date:  2021-12-03

Review 7.  BRAF inhibitors: resistance and the promise of combination treatments for melanoma.

Authors:  Merope Griffin; Daniele Scotto; Debra H Josephs; Silvia Mele; Silvia Crescioli; Heather J Bax; Giulia Pellizzari; Matthew D Wynne; Mano Nakamura; Ricarda M Hoffmann; Kristina M Ilieva; Anthony Cheung; James F Spicer; Sophie Papa; Katie E Lacy; Sophia N Karagiannis
Journal:  Oncotarget       Date:  2017-08-03
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.